Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2464605016 | Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2470965011 | Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3120481000052111 | tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Is a | Product containing tositumomab (medicinal product) | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Is a | Product containing iodine-131 (medicinal product) | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has active ingredient | Iodine radioisotope | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has active ingredient | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has active ingredient | Tositumomab (substance) | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has active ingredient | radiofarmaceutiskt läkemedel | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Has active ingredient | Iodine-131 (substance) | false | Inferred relationship | Some | ||
tositumomab 14 mg/ml/jod 131 5,6 mCi/ml/tositumomab 1,1 mg/ml, injektionsvätska, flaska | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set